Abstract:Abstract Background Mesenchymal stromal cells, which can be obtained in a large quantity from bone marrow easily, are non-hematopoietic multipotent stem cells that cannot differentiate into hematopoietic components in physiological condition. Induced pluripotent hematopoietic stem cells (iP-HSCs) may be an alternative graft source for autologous hematopoietic stem cell transplantation (HSCT) without malignant cell contamination and provide a disease-specific model for studying the underlying pathogenesis. This study aimed to generate putative induced pluripotent stem cells (iPSCs) from bone marrow-derived MSCs (BM-MSCs) using the plasmid pcDNA3.1, only containing OCT4. Methods BM-MSCs with stable ectopic OCT4 expression were established using a conventional plasmid vector, and then cultured in ES medium to form ESC-like clones. The obtained putative iPSCs were divided into two groups and treated with two different growth factor cocktails to induce differentiation into hematopoietic progenitor cells. Furthermore, putative iPSCs were injected subcutaneously into nude mice and the resulting cells were analyzed. Results The generated putative iPSCs were similar to human embryonic stem cells (ESCs) in terms of morphology, surface marker expression, telomerase activity and in vitro differentiation. CD34 + progenitor cells were obtained from the putative iPSCs following treatment with specific factors. The proportion of CD34 + progenitor cells were higher in differentiated cells (16.16 ± 1.27% and 25.40 ± 3.08% at days 14 and 21, respectively) compared to that of untransfected parental BM-MSCs (0.93 ± 0.46%) or undifferentiated cells (1.58 ± 1.29%) (P < 0.05) as determined using flow cytometry. After induction using the second growth factor cocktail and induction process,, the proportion of CD34 + cells reached 31.39 ± 3.60% and 73.68 ± 6.63% at days 14 and 21, respectively. These differentiated cells expressed the mesodermal hematopoietic transcription factor Brachyury. Conclusions This cell induction system developed in this study may provide a possible source of grafts-enriched CD34 + progenitor cells without malignant cell contamination for clinical use and to generate patient-specific cell models for studying of the mechanisms of hematopoiesis and related diseases.

Generation of a control induced pluripotent stem cell line (SDUCHi001-A) from a healthy male donor

Establishment of induced pluripotent stem cell line SDPHi003-A from a healthy male donor

Establishment of an Induced Pluripotent Stem Cell Line (Sdchi011-A) from a Healthy Chinese Female Donor

An achievement has been made in establishing an induced pluripotent stem cell line (SDPHi005-A) from a healthy Chinese male donor

Generation of a Human Induced Pluripotent Stem Cell Line (Shupli001-A) from PBMCs of a Healthy Male Donor.

Generation of a Human Control PBMC Derived Ips Cell Line TUSMi001-A from a Healthy Male Donor of Han Chinese Genetic Background

Generation of a Human Induced Pluripotent Stem Cell Line (Shupli002-A) from PBMCs of a Healthy Female Donor

Generation of Induced Pluripotent Stem Cell Line (Zzui007-A) from a 52-Year-old Patient with a Novel CHCHD2 Gene Mutation in Parkinson's Disease.

Establishing an induced pluripotent stem cell line (SDPHi006-A) from a healthy Chinese female donor represents an accomplishment

Generation of a Human Induced Pluripotent Stem Cell Line from a 65-Year Old Healthy Female Donor with Chinese Han Genetic Background

Generation of Induced Pluripotent Stem Cells Using Recombinant Proteins.

Efficient generation of induced pluripotent stem cell lines from healthy donors' peripheral blood mononuclear cells from different genders

Advances in Reprogramming of Peripheral Blood Cells to Induced Pluripotent Stem Cells

Construction of Induced Pluripotent Stem Cell Line (Zzui031-A) of a Healthy Young Chinese Han Male

Induced Pluripotent Stem Cell Line (Zzuneui011-A) Derived from Peripheral Blood Mononuclear Cells (pbmcs) of a Healthy 27-Year-old Female Individual.

Generation of human induced pluripotent stem cell (DMSCi001-A) line from hematopoietic stem cells of a healthy female donor

Generation of an induced pluripotent stem cell line SDPHi002-A from a patient with lung cancer

Generation and characterisation of a human induced pluripotent stem cell line, NIMHi007-A, from peripheral blood mononuclear cells derived from an adult healthy female

Introduction of OCT4 into Human Bone-Marrow Derived Mesenchymal Stromal Cells Generates Putative Ips Cells with the Potential to Differentiate into CD34+ Hematopoietic Progenitor Cells Ex Vivo

Generation and characterization of human-derived iPSC lines from one pair of dizygotic twins discordant for schizophrenia.

Generation and characterization of the iPS cell line (SYSUSHi001-A) derived from the peripheral blood mononuclear cells (PBMCs) of a 33-year-old patient with acute myeloid leukemia (AML)